Fri, April 12, 2013
Thu, April 11, 2013

Chris Howerton Maintained (ACAD) at Strong Buy with Increased Target to $18 on, Apr 12th, 2013

Chris Howerton of Jefferies, Maintained "ACADIA Pharmaceuticals Inc." (ACAD) at Strong Buy with Increased Target from $13 to $18 on, Apr 12th, 2013.

Chris, nor any peers, have made any analyst calls on ACAD in the last 4 months.

Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30